Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI +3.37%73 PE Ratio (TTM) is 21.30 as of Jul. 30, 2026, which is 0% above its 10-year median of 21.20. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 73/100 and a GF Value™ of ₹120.80 (Fairly Valued). The stock has 7 warning signs investors should review. Among 435 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 60.46% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-30), QMS Medical Allied Services's share price is
₹116.34.
QMS Medical Allied Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.46. Therefore, QMS Medical Allied Services's PE Ratio (TTM) for today is 21.30.
Warning Sign:
QMS Medical Allied Services Ltd stock PE Ratio (=20.48) is close to 1-year high of 20.48.
The historical rank and industry rank for QMS Medical Allied Services's PE Ratio (TTM) or its related term are showing as below:
NSE:QMSMEDI'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 10.67 Med: 21.2 Max: 179.25
Current: 21.3
During the past 7 years, the highest PE Ratio (TTM) of QMS Medical Allied Services was 179.25. The lowest was 10.67. And the median was 21.20.
NSE:QMSMEDI's PE Ratio (TTM) is ranked better than 60.46% of 435
companies
in the Medical Devices & Instruments industry
Industry Median: 25.45
vs NSE:QMSMEDI: 21.30
During the past 7 years, QMS Medical Allied Services's highest 3-Year average EPS without NRI Growth Rate was 11.60% per year. The lowest was -6.20% per year. And the median was 5.40% per year.
QMS Medical Allied Services (NSE:QMSMEDI) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
QMS Medical Allied Services PE Ratio (TTM) Related Terms
QMS Medical Allied Services PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QMSMEDI vs ISRG, BDX, MDLN: PE Ratio (TTM) Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's PE Ratio (TTM) falls into.
QMS Medical Allied Services PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
QMS Medical Allied Services's Share Price of today is ₹116.34.
QMS Medical Allied Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.46.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
QMS Medical Allied Services (NSE:QMSMEDI) has a PE Ratio (TTM) of 21.30 as of Jul. 30, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on QMS Medical Allied Services and its competitors. This is near median its historical median of 21.20. Over the past decade, QMS Medical Allied Services' PE Ratio (TTM) has ranged from 10.67 to 179.25. According to the industry distribution chart, QMS Medical Allied Services ranks #172 out of 435 companies in the Medical Devices & Instruments industry, placing it in the top 39.5%.
Is QMS Medical Allied Services' PE Ratio (TTM) too high?
QMS Medical Allied Services' current PE Ratio (TTM) of 21.30 is near median its 10-year median of 21.20. Over the past 10 years, this metric has ranged from a low of 10.67 to a high of 179.25. The Medical Devices & Instruments industry median PE Ratio (TTM) is 25.45. QMS Medical Allied Services' value of 21.30 is 16.3% below this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #172 out of 435 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' PE Ratio (TTM) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #172 out of 435 companies for PE Ratio (TTM). This puts QMS Medical Allied Services in the upper half of its industry. The industry median PE Ratio (TTM) is 25.45. QMS Medical Allied Services' value of 21.30 is 16.3% below this benchmark. Historically, QMS Medical Allied Services' own PE Ratio (TTM) has ranged from 10.67 to 179.25 over the past decade. While the company's 10-year median is 21.20 vs. the industry median of 25.45, QMS Medical Allied Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 25.45, based on 435 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current PE Ratio (TTM) of 21.30 is 16.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 25.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current PE Ratio (TTM) is 21.30, which is near median its own 10-year median of 21.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Fairly Valued. The stock's GF Value™ is ₹120.80, compared to a current price of ₹116.34 — trading 3.7% below its estimated fair value. The current PE Ratio (TTM) is 21.30, which is near median its 10-year median of 21.20 and 16.3% below the Medical Devices & Instruments industry median of 25.45. QMS Medical Allied Services' overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current PE Ratio (TTM) is 21.30 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹116.34 is trading 3.7% below its estimated GF Value™ of ₹120.80.
GuruFocus considers QMS Medical Allied Services to be Fairly Valued.
Key valuation signals for NSE:QMSMEDI:
PE Ratio (TTM): 21.30 (near median its 10-year median of 21.20)
GF Value™: ₹120.80 vs. price of ₹116.34 (3.7% below fair value)
Industry Position: 16.3% below the Medical Devices & Instruments median (#172 of 435)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
73GF Score
Get the complete analysis for NSE:QMSMEDI
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
